November 2022 Vol 13, No 11
November 2022 Vol 13, No 11 | November 17, 2022
Connect with Us on Facebook, Attend a Facebook Live Session, Listen to a Podcast, or Check Out Our Blog
November 2022 Vol 13, No 11 | November 17, 2022
This qualitative descriptive study explored the benefits of ACP as an expanded role for the ONN by describing the perspectives of appointed healthcare power of attorney (HCPOA) agents for lung cancer patients who had their ACP discussion led by an ONN.
November 2022 Vol 13, No 11 | November 17, 2022
His new price controls might have killed Amgen’s breakthrough drug for lung cancer
November 2022 Vol 13, No 11 | November 17, 2022
The CATCH for November 2022 is awarded to Sara Sanchez, BSN, RN, a complex GI oncology nurse navigator with the Sarah Cannon Cancer Institute at Medical City Plano in Texas.
November 2022 Vol 13, No 11 | November 17, 2022
To examine how SEs impacting QOL in pts with ABC are perceived.
November 2022 Vol 13, No 11 | November 17, 2022
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
November 2022 Vol 13, No 11 | November 17, 2022
MF is a rare bone marrow cancer characterized by fibrosis, abnormal blood cell production, and dysregulated JAK/STAT signaling.1,2
November 2022 Vol 13, No 11 | November 17, 2022
To assess OS at an updated cutoff with additional follow-up.
November 2022 Vol 13, No 11 | November 17, 2022
Here, we present the long-term follow-up data at up to 40 months.
- 1
- 2
Page 1 of 2
Results 1 - 9 of 12
Results 1 - 9 of 12